TP53 mutation in therapy-related myeloid neoplasm defines a distinct molecular subtype

Blood. 2023 Mar 2;141(9):1087-1091. doi: 10.1182/blood.2022018236.

Devendra Hiwase^{1

2

3

4}, Christopher Hahn^{4

5}, Elizabeth Ngoc Hoa Tran^{2

3}, Rakchha Chhetri^{1

2

3}, Anmol Baranwal⁶, Aref Al-Kali⁶, Kirsty Sharplin¹, Dariusz Ladon⁵, Rachel Hollins⁵, Patricia Greipp⁷, Monika Kutyna^{1

2

3}, Hassan Alkhateeb⁶, Talha Badar⁸, Paul Wang⁹, David M Ross^{1

2

3

4}, Deepak Singhal^{1

2}, Naranie Shanmuganathan^{1

2}, Peter Bardy¹, Ashanka Beligaswatte¹, David Yeung^{1

2}, Mark R Litzow⁶, Abhishek Mangaonkar⁶, Pratyush Giri¹, Cindy Lee¹, Angie Yong¹, Noemi Horvath¹, Nimit Singhal¹, Raghu Gowda¹, William Hogan⁶, Naseema Gangat⁶, Mrinal Patnaik⁶, Kebede Begna⁶, Ing S Tiong¹⁰, Andrew Wei¹⁰, Sharad Kumar⁴, Anna Brown^{4

5}, Hamish Scott^{4

5}, Daniel Thomas^{1

2

3}, Chung H Kok^{2

3}, Ayalew Tefferi⁶, Mithun Vinod Shah⁶

¹ Department of Haematology, Royal Adelaide Hospital, Central Adelaide Local Health Network, Adelaide, SA, Australia.
² Precision Medicine Theme, South Australian Health and Medical Research Institute (SAHMRI), Adelaide, SA, Australia.
³ Adelaide Medical School, University of Adelaide, Adelaide, SA, Australia.
⁴ Centre for Cancer Biology, University of South Australia and SA Pathology, Adelaide, SA, Australia.
⁵ Genetic and Molecular Pathology, SA Pathology, Adelaide, SA, Australia.
⁶ Division of Hematology, Mayo Clinic, Rochester, MN.
⁷ Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN.
⁸ Department of Hematology/Oncology, Mayo Clinic, Jacksonville, FL.
⁹ ACRF Cancer Genomic Facility, SA Pathology, Adelaide, SA, Australia.
¹⁰ Department of Haematology, The Alfred Hospital and Monash University, Melbourne, VIC, Australia.

No abstract available

MeSH terms